Quick Answer
Pacira BioSciences, Inc. reported Long Term Debt of $372.19 million for the year ending 2025.
- Pacira BioSciences, Inc. showed a decrease of -3.0% in Long Term Debt from 2024 to 2025.
- This data is from Pacira BioSciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $20.36 million | Q3 2011: $20.60 million | Q1 2012: $23.63 million | Q2 2012: $24.67 million | Q3 2012: $24.93 million | Q1 2013: $95.86 million | Q2 2013: $96.89 million | Q3 2013: $0.00 | Q3 2025: $376.72 million.
- Over the full 6 years of available data (2010 to 2025), Pacira BioSciences, Inc.'s Long Term Debt has grown by 1,601.9%.
- Historical annual values: Fiscal year 2025: $372.19 million | Fiscal year 2024: $383.55 million | Fiscal year 2013: $0.00 | Fiscal year 2012: $25.19 million | Fiscal year 2011: $18.54 million | Fiscal year 2010: $21.87 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: